Views Reference

A new study from Johns Hopkins University shows children have a stronger antibody response to COVID-19 infections, specifically, infants and toddlers.
 

After one of the most turbulent periods in air travel history — loaded with new rules and regulations and plenty of unruly and disruptive passengers — airlines want to jettison COVID-era safety precautions for flights.

Experts say certain individuals, such as the immunocompromised, should still consider masking up in-flight.
 

Even as most eligible Americans have yet to receive their first COVID-19 vaccine boosters, Pfizer and Moderna have now asked the FDA to authorize yet another booster dose -- especially for elderly Americans, a group that tends to have weaker immune protection.
 

Gun violence experts say ghost guns are easy to assemble and difficult to trace.
He is featured at the :23 mark.
 

Most people who have the coronavirus recover in a couple of weeks but some, even those with mild cases, continue to have symptoms for weeks or even months later.
 

As health authorities brace for another coronavirus wave, the US is still deeply divided over its pandemic future – even as most states relax restrictions
 

With coronavirus cases rising in parts of Europe and Asia, scientists worry that an extra-contagious version of the omicron variant may soon push cases up in the United States too.
 

The new omicron sub-variant, BA.2 is causing cases to go up in several European countries, and many are wondering if the United States will see another surge in the coming weeks.
 

Conspiracy theories around COVID-19 and an ever-widening political divide led to a terrifying uptick in harassment against America's public health workers, new research finds.
A study by BSPH researchers is cited. 

Scarcely two months after the Omicron variant drove coronavirus case numbers to frightening heights in the United States, scientists and health officials are bracing for another swell in the pandemic and, with it, the first major test of the country’s strategy of living with the virus while limiting its impact.
Jennifer Nuzzo and David Dowdy are quoted. 

While protection against mild illness waned over time, the mRNA vaccines from Moderna and Pfizer-BioNTech provided a robust shield against the worst outcomes.